HEADER CELL CYCLE, SIGNALING PROTEIN 26-NOV-03 1RLU TITLE MYCOBACTERIUM TUBERCULOSIS FTSZ IN COMPLEX WITH GTP-GAMMA-S COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN FTSZ; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: FTSZ, RV2150C, MT2209, MTCY270.18, MB2174C; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET15B; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PJD168 KEYWDS CELL CYCLE, TUBULIN, GTPASE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.K.W.LEUNG,E.L.WHITE,L.J.ROSS,R.C.REYNOLDS,J.A.DEVITO,D.W.BORHANI REVDAT 5 23-AUG-23 1RLU 1 REMARK SEQADV REVDAT 4 11-OCT-17 1RLU 1 REMARK REVDAT 3 13-JUL-11 1RLU 1 VERSN REVDAT 2 24-FEB-09 1RLU 1 VERSN REVDAT 1 31-AUG-04 1RLU 0 JRNL AUTH A.K.LEUNG,E.LUCILE WHITE,L.J.ROSS,R.C.REYNOLDS,J.A.DEVITO, JRNL AUTH 2 D.W.BORHANI JRNL TITL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS FTSZ REVEALS JRNL TITL 2 UNEXPECTED, G PROTEIN-LIKE CONFORMATIONAL SWITCHES. JRNL REF J.MOL.BIOL. V. 342 953 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15342249 JRNL DOI 10.1016/J.JMB.2004.07.061 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.W.BORHANI,E.L.WHITE REMARK 1 TITL POLYMERIZATION OF C-TERMINALLY TRUNCATED MYCOBACTERIUM REMARK 1 TITL 2 TUBERCULOSIS FTSZ IS UNLIKELY TO BE PHYSIOLOGICALLY RELEVANT REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 DOI 10.1107/S0907444900011835 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.K.W.LEUNG,E.L.WHITE,L.J.ROSS,D.W.BORHANI REMARK 1 TITL CRYSTALLIZATION OF THE MYCOBACTERIUM TUBERCULOSIS REMARK 1 TITL 2 CELL-DIVISION PROTEIN FTSZ REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 56 1634 2000 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 11092931 REMARK 1 DOI 10.1128/JB.182.14.4028-4034.2000 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.L.WHITE,L.J.ROSS,R.C.REYNOLDS,L.E.SEITZ,G.D.MOORE, REMARK 1 AUTH 2 D.W.BORHANI REMARK 1 TITL SLOW POLYMERIZATION OF MYCOBACTERIUM TUBERCULOSIS FTSZ REMARK 1 REF J.BACTERIOL. V. 182 4028 2000 REMARK 1 REFN ISSN 0021-9193 REMARK 1 PMID 10869082 REMARK 1 DOI 10.1093/JAC/DKF075 REMARK 1 REFERENCE 4 REMARK 1 AUTH E.L.WHITE,W.J.SULING,L.J.ROSS,L.E.SEITZ,R.C.REYNOLDS REMARK 1 TITL 2-ALKOXYCARBONYLAMINOPYRIDINES: INHIBITORS OF MYCOBACTERIUM REMARK 1 TITL 2 TUBERCULOSIS FTSZ REMARK 1 REF J.ANTIMICROB.CHEMOTHER. V. 50 111 2002 REMARK 1 REFN ISSN 0305-7453 REMARK 1 PMID 12096015 REMARK 1 DOI 10.1093/JAC/DKF075 REMARK 2 REMARK 2 RESOLUTION. 2.08 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.27 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.08 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 42294 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 2317 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.08 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1652 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4213 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 268 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.28000 REMARK 3 B22 (A**2) : -0.28000 REMARK 3 B33 (A**2) : 0.42000 REMARK 3 B12 (A**2) : -0.14000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.168 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.158 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.281 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4295 ; 0.020 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5817 ; 1.681 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 594 ; 5.739 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 706 ; 0.114 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3171 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1949 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 256 ; 0.140 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 68 ; 0.244 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.147 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2918 ; 1.168 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4617 ; 2.143 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1377 ; 3.528 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1200 ; 6.020 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: X-PLOR-GENERATED BULK SOLVENT PARTIAL REMARK 3 STRUCTURE FACTORS WERE USED IN REFMAC AS PARTIAL STRUCTURE REMARK 3 FACTORS (FPART/PHIPART), EXCEPT IN LAST ROUND, WHERE REFMAC REMARK 3 BABINET MODEL WITH MASK WAS USED. REMARK 4 REMARK 4 1RLU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000020870. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9235 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS/MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, TRUNCATE REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA, TRUNCATE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44782 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.080 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.08 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 50.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PARTIALLY REFINED MODEL OF THE MYCOBACTERIUM REMARK 200 TUBERCULOSIS FTSZ/CITRATE COMPLEX, PDB ENTRY 1RQ2. REMARK 200 REMARK 200 REMARK: GTP-GAMMA-S INTRODUCED BY SOAKING CRYSTAL, GROWN UNDER REMARK 200 FTSZ/CITRATE COMPLEX CONDITIONS (PDB ENTRY 1RQ2), WITH 2MM GTP - REMARK 200 GAMMA-S AND 10MM MGCL2 OVERNIGHT. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.1M SODIUM CITRATE, REMARK 280 0.2M AMMONIUM ACETATE, 2MM SRI-7614, ETHYL (6-AMINO-2,3-DIHYDRO- REMARK 280 4-PHENYL-1H-PYRIDO[4,3-B][1,4]DIAZEPIN-8-YL)-CARBAMATE, WAS REMARK 280 INCLUDED AS WELL, BUT WAS NOT LOCATED IN THE FINAL STRUCTURE, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 5.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 119.01467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 59.50733 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 89.26100 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 29.75367 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 148.76833 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 PRO A 3 REMARK 465 PRO A 4 REMARK 465 HIS A 5 REMARK 465 ASN A 6 REMARK 465 TYR A 7 REMARK 465 ASP A 313 REMARK 465 VAL A 314 REMARK 465 SER A 315 REMARK 465 GLY A 316 REMARK 465 PRO A 317 REMARK 465 GLY A 318 REMARK 465 ARG A 319 REMARK 465 LYS A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 MET A 323 REMARK 465 GLY A 324 REMARK 465 GLU A 325 REMARK 465 THR A 326 REMARK 465 GLY A 327 REMARK 465 GLY A 328 REMARK 465 ALA A 329 REMARK 465 HIS A 330 REMARK 465 ARG A 331 REMARK 465 ILE A 332 REMARK 465 GLU A 333 REMARK 465 SER A 334 REMARK 465 ALA A 335 REMARK 465 LYS A 336 REMARK 465 ALA A 337 REMARK 465 GLY A 338 REMARK 465 LYS A 339 REMARK 465 LEU A 340 REMARK 465 THR A 341 REMARK 465 SER A 342 REMARK 465 THR A 343 REMARK 465 LEU A 344 REMARK 465 PHE A 345 REMARK 465 GLU A 346 REMARK 465 PRO A 347 REMARK 465 VAL A 348 REMARK 465 ASP A 349 REMARK 465 ALA A 350 REMARK 465 VAL A 351 REMARK 465 SER A 352 REMARK 465 VAL A 353 REMARK 465 PRO A 354 REMARK 465 LEU A 355 REMARK 465 HIS A 356 REMARK 465 THR A 357 REMARK 465 ASN A 358 REMARK 465 GLY A 359 REMARK 465 ALA A 360 REMARK 465 THR A 361 REMARK 465 LEU A 362 REMARK 465 SER A 363 REMARK 465 ILE A 364 REMARK 465 GLY A 365 REMARK 465 GLY A 366 REMARK 465 ASP A 367 REMARK 465 ASP A 368 REMARK 465 ASP A 369 REMARK 465 ASP A 370 REMARK 465 VAL A 371 REMARK 465 ASP A 372 REMARK 465 VAL A 373 REMARK 465 PRO A 374 REMARK 465 PRO A 375 REMARK 465 PHE A 376 REMARK 465 MET A 377 REMARK 465 ARG A 378 REMARK 465 ARG A 379 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 PRO B 3 REMARK 465 PRO B 4 REMARK 465 HIS B 5 REMARK 465 ARG B 60 REMARK 465 ASP B 61 REMARK 465 SER B 62 REMARK 465 THR B 63 REMARK 465 ARG B 64 REMARK 465 GLY B 65 REMARK 465 LEU B 66 REMARK 465 GLY B 67 REMARK 465 ALA B 68 REMARK 465 GLY B 69 REMARK 465 GLY B 170 REMARK 465 ASP B 171 REMARK 465 ALA B 172 REMARK 465 ALA B 173 REMARK 465 ASP B 313 REMARK 465 VAL B 314 REMARK 465 SER B 315 REMARK 465 GLY B 316 REMARK 465 PRO B 317 REMARK 465 GLY B 318 REMARK 465 ARG B 319 REMARK 465 LYS B 320 REMARK 465 PRO B 321 REMARK 465 VAL B 322 REMARK 465 MET B 323 REMARK 465 GLY B 324 REMARK 465 GLU B 325 REMARK 465 THR B 326 REMARK 465 GLY B 327 REMARK 465 GLY B 328 REMARK 465 ALA B 329 REMARK 465 HIS B 330 REMARK 465 ARG B 331 REMARK 465 ILE B 332 REMARK 465 GLU B 333 REMARK 465 SER B 334 REMARK 465 ALA B 335 REMARK 465 LYS B 336 REMARK 465 ALA B 337 REMARK 465 GLY B 338 REMARK 465 LYS B 339 REMARK 465 LEU B 340 REMARK 465 THR B 341 REMARK 465 SER B 342 REMARK 465 THR B 343 REMARK 465 LEU B 344 REMARK 465 PHE B 345 REMARK 465 GLU B 346 REMARK 465 PRO B 347 REMARK 465 VAL B 348 REMARK 465 ASP B 349 REMARK 465 ALA B 350 REMARK 465 VAL B 351 REMARK 465 SER B 352 REMARK 465 VAL B 353 REMARK 465 PRO B 354 REMARK 465 LEU B 355 REMARK 465 HIS B 356 REMARK 465 THR B 357 REMARK 465 ASN B 358 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 THR B 361 REMARK 465 LEU B 362 REMARK 465 SER B 363 REMARK 465 ILE B 364 REMARK 465 GLY B 365 REMARK 465 GLY B 366 REMARK 465 ASP B 367 REMARK 465 ASP B 368 REMARK 465 ASP B 369 REMARK 465 ASP B 370 REMARK 465 VAL B 371 REMARK 465 ASP B 372 REMARK 465 VAL B 373 REMARK 465 PRO B 374 REMARK 465 PRO B 375 REMARK 465 PHE B 376 REMARK 465 MET B 377 REMARK 465 ARG B 378 REMARK 465 ARG B 379 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 29 CD OE1 OE2 REMARK 470 LYS A 33 CE NZ REMARK 470 ARG A 64 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 66 CG CD1 CD2 REMARK 470 ARG A 181 NE CZ NH1 NH2 REMARK 470 LYS A 236 CG CD CE NZ REMARK 470 GLU A 252 CG CD OE1 OE2 REMARK 470 ASN B 6 CG OD1 ND2 REMARK 470 LEU B 8 CG CD1 CD2 REMARK 470 GLU B 73 CD OE1 OE2 REMARK 470 LYS B 77 CD CE NZ REMARK 470 LYS B 120 CG CD CE NZ REMARK 470 ARG B 140 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 236 CG CD CE NZ REMARK 470 ASP B 301 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 53 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP A 94 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 140 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ASP A 301 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 53 CB - CG - OD2 ANGL. DEV. = 6.8 DEGREES REMARK 500 ASP B 156 CB - CG - OD2 ANGL. DEV. = 7.1 DEGREES REMARK 500 ASP B 286 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 200 57.56 -149.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RQ2 RELATED DB: PDB REMARK 900 MYCOBACTERIUM TUBERCULOSIS FTSZ IN COMPLEX WITH CITRATE REMARK 900 RELATED ID: 1RQ7 RELATED DB: PDB REMARK 900 MYCOBACTERIUM TUBERCULOSIS FTSZ IN COMPLEX WITH GDP DBREF 1RLU A 1 379 UNP P64170 FTSZ_MYCTU 1 379 DBREF 1RLU B 1 379 UNP P64170 FTSZ_MYCTU 1 379 SEQADV 1RLU GLY A -2 UNP P64170 CLONING ARTIFACT SEQADV 1RLU SER A -1 UNP P64170 CLONING ARTIFACT SEQADV 1RLU HIS A 0 UNP P64170 CLONING ARTIFACT SEQADV 1RLU GLY B -2 UNP P64170 CLONING ARTIFACT SEQADV 1RLU SER B -1 UNP P64170 CLONING ARTIFACT SEQADV 1RLU HIS B 0 UNP P64170 CLONING ARTIFACT SEQRES 1 A 382 GLY SER HIS MET THR PRO PRO HIS ASN TYR LEU ALA VAL SEQRES 2 A 382 ILE LYS VAL VAL GLY ILE GLY GLY GLY GLY VAL ASN ALA SEQRES 3 A 382 VAL ASN ARG MET ILE GLU GLN GLY LEU LYS GLY VAL GLU SEQRES 4 A 382 PHE ILE ALA ILE ASN THR ASP ALA GLN ALA LEU LEU MET SEQRES 5 A 382 SER ASP ALA ASP VAL LYS LEU ASP VAL GLY ARG ASP SER SEQRES 6 A 382 THR ARG GLY LEU GLY ALA GLY ALA ASP PRO GLU VAL GLY SEQRES 7 A 382 ARG LYS ALA ALA GLU ASP ALA LYS ASP GLU ILE GLU GLU SEQRES 8 A 382 LEU LEU ARG GLY ALA ASP MET VAL PHE VAL THR ALA GLY SEQRES 9 A 382 GLU GLY GLY GLY THR GLY THR GLY GLY ALA PRO VAL VAL SEQRES 10 A 382 ALA SER ILE ALA ARG LYS LEU GLY ALA LEU THR VAL GLY SEQRES 11 A 382 VAL VAL THR ARG PRO PHE SER PHE GLU GLY LYS ARG ARG SEQRES 12 A 382 SER ASN GLN ALA GLU ASN GLY ILE ALA ALA LEU ARG GLU SEQRES 13 A 382 SER CYS ASP THR LEU ILE VAL ILE PRO ASN ASP ARG LEU SEQRES 14 A 382 LEU GLN MET GLY ASP ALA ALA VAL SER LEU MET ASP ALA SEQRES 15 A 382 PHE ARG SER ALA ASP GLU VAL LEU LEU ASN GLY VAL GLN SEQRES 16 A 382 GLY ILE THR ASP LEU ILE THR THR PRO GLY LEU ILE ASN SEQRES 17 A 382 VAL ASP PHE ALA ASP VAL LYS GLY ILE MET SER GLY ALA SEQRES 18 A 382 GLY THR ALA LEU MET GLY ILE GLY SER ALA ARG GLY GLU SEQRES 19 A 382 GLY ARG SER LEU LYS ALA ALA GLU ILE ALA ILE ASN SER SEQRES 20 A 382 PRO LEU LEU GLU ALA SER MET GLU GLY ALA GLN GLY VAL SEQRES 21 A 382 LEU MET SER ILE ALA GLY GLY SER ASP LEU GLY LEU PHE SEQRES 22 A 382 GLU ILE ASN GLU ALA ALA SER LEU VAL GLN ASP ALA ALA SEQRES 23 A 382 HIS PRO ASP ALA ASN ILE ILE PHE GLY THR VAL ILE ASP SEQRES 24 A 382 ASP SER LEU GLY ASP GLU VAL ARG VAL THR VAL ILE ALA SEQRES 25 A 382 ALA GLY PHE ASP VAL SER GLY PRO GLY ARG LYS PRO VAL SEQRES 26 A 382 MET GLY GLU THR GLY GLY ALA HIS ARG ILE GLU SER ALA SEQRES 27 A 382 LYS ALA GLY LYS LEU THR SER THR LEU PHE GLU PRO VAL SEQRES 28 A 382 ASP ALA VAL SER VAL PRO LEU HIS THR ASN GLY ALA THR SEQRES 29 A 382 LEU SER ILE GLY GLY ASP ASP ASP ASP VAL ASP VAL PRO SEQRES 30 A 382 PRO PHE MET ARG ARG SEQRES 1 B 382 GLY SER HIS MET THR PRO PRO HIS ASN TYR LEU ALA VAL SEQRES 2 B 382 ILE LYS VAL VAL GLY ILE GLY GLY GLY GLY VAL ASN ALA SEQRES 3 B 382 VAL ASN ARG MET ILE GLU GLN GLY LEU LYS GLY VAL GLU SEQRES 4 B 382 PHE ILE ALA ILE ASN THR ASP ALA GLN ALA LEU LEU MET SEQRES 5 B 382 SER ASP ALA ASP VAL LYS LEU ASP VAL GLY ARG ASP SER SEQRES 6 B 382 THR ARG GLY LEU GLY ALA GLY ALA ASP PRO GLU VAL GLY SEQRES 7 B 382 ARG LYS ALA ALA GLU ASP ALA LYS ASP GLU ILE GLU GLU SEQRES 8 B 382 LEU LEU ARG GLY ALA ASP MET VAL PHE VAL THR ALA GLY SEQRES 9 B 382 GLU GLY GLY GLY THR GLY THR GLY GLY ALA PRO VAL VAL SEQRES 10 B 382 ALA SER ILE ALA ARG LYS LEU GLY ALA LEU THR VAL GLY SEQRES 11 B 382 VAL VAL THR ARG PRO PHE SER PHE GLU GLY LYS ARG ARG SEQRES 12 B 382 SER ASN GLN ALA GLU ASN GLY ILE ALA ALA LEU ARG GLU SEQRES 13 B 382 SER CYS ASP THR LEU ILE VAL ILE PRO ASN ASP ARG LEU SEQRES 14 B 382 LEU GLN MET GLY ASP ALA ALA VAL SER LEU MET ASP ALA SEQRES 15 B 382 PHE ARG SER ALA ASP GLU VAL LEU LEU ASN GLY VAL GLN SEQRES 16 B 382 GLY ILE THR ASP LEU ILE THR THR PRO GLY LEU ILE ASN SEQRES 17 B 382 VAL ASP PHE ALA ASP VAL LYS GLY ILE MET SER GLY ALA SEQRES 18 B 382 GLY THR ALA LEU MET GLY ILE GLY SER ALA ARG GLY GLU SEQRES 19 B 382 GLY ARG SER LEU LYS ALA ALA GLU ILE ALA ILE ASN SER SEQRES 20 B 382 PRO LEU LEU GLU ALA SER MET GLU GLY ALA GLN GLY VAL SEQRES 21 B 382 LEU MET SER ILE ALA GLY GLY SER ASP LEU GLY LEU PHE SEQRES 22 B 382 GLU ILE ASN GLU ALA ALA SER LEU VAL GLN ASP ALA ALA SEQRES 23 B 382 HIS PRO ASP ALA ASN ILE ILE PHE GLY THR VAL ILE ASP SEQRES 24 B 382 ASP SER LEU GLY ASP GLU VAL ARG VAL THR VAL ILE ALA SEQRES 25 B 382 ALA GLY PHE ASP VAL SER GLY PRO GLY ARG LYS PRO VAL SEQRES 26 B 382 MET GLY GLU THR GLY GLY ALA HIS ARG ILE GLU SER ALA SEQRES 27 B 382 LYS ALA GLY LYS LEU THR SER THR LEU PHE GLU PRO VAL SEQRES 28 B 382 ASP ALA VAL SER VAL PRO LEU HIS THR ASN GLY ALA THR SEQRES 29 B 382 LEU SER ILE GLY GLY ASP ASP ASP ASP VAL ASP VAL PRO SEQRES 30 B 382 PRO PHE MET ARG ARG HET GSP A 401 32 HET GOL B 404 6 HETNAM GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GSP C10 H16 N5 O13 P3 S FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *268(H2 O) HELIX 1 1 GLY A 17 GLN A 30 1 14 HELIX 2 2 ASP A 43 MET A 49 1 7 HELIX 3 3 GLY A 59 ARG A 64 1 6 HELIX 4 4 ASP A 71 ALA A 82 1 12 HELIX 5 5 ALA A 82 ARG A 91 1 10 HELIX 6 6 GLY A 105 GLY A 122 1 18 HELIX 7 7 PHE A 133 GLU A 136 5 4 HELIX 8 8 GLY A 137 CYS A 155 1 19 HELIX 9 9 ASN A 163 LEU A 167 1 5 HELIX 10 10 SER A 175 THR A 200 1 26 HELIX 11 11 ASP A 207 SER A 216 1 10 HELIX 12 12 GLY A 232 SER A 244 1 13 HELIX 13 13 PRO A 245 GLU A 248 5 4 HELIX 14 14 SER A 250 ALA A 254 5 5 HELIX 15 15 GLY A 268 ALA A 283 1 16 HELIX 16 16 ASP A 297 GLY A 300 5 4 HELIX 17 17 GLY B 17 GLY B 31 1 15 HELIX 18 18 ASP B 71 ALA B 82 1 12 HELIX 19 19 ALA B 82 ARG B 91 1 10 HELIX 20 20 THR B 106 LEU B 121 1 16 HELIX 21 21 PHE B 133 GLY B 137 5 5 HELIX 22 22 ARG B 139 SER B 141 5 3 HELIX 23 23 ASN B 142 CYS B 155 1 14 HELIX 24 24 ASP B 164 MET B 169 5 6 HELIX 25 25 SER B 175 THR B 200 1 26 HELIX 26 26 ASP B 207 SER B 216 1 10 HELIX 27 27 GLY B 232 ASN B 243 1 12 HELIX 28 28 SER B 244 GLU B 248 5 5 HELIX 29 29 GLY B 268 ALA B 283 1 16 SHEET 1 A11 ASN A 288 ILE A 295 0 SHEET 2 A11 GLY A 256 GLY A 263 1 N MET A 259 O ILE A 290 SHEET 3 A11 GLU A 302 ALA A 310 -1 O ARG A 304 N ALA A 262 SHEET 4 A11 GLY A 219 ARG A 229 -1 N GLY A 226 O VAL A 305 SHEET 5 A11 THR A 157 PRO A 162 1 N LEU A 158 O ALA A 221 SHEET 6 A11 LEU A 124 ARG A 131 1 N GLY A 127 O ILE A 159 SHEET 7 A11 MET A 95 GLY A 101 1 N VAL A 96 O LEU A 124 SHEET 8 A11 ILE A 11 ILE A 16 1 N VAL A 14 O PHE A 97 SHEET 9 A11 GLU A 36 ASN A 41 1 O GLU A 36 N VAL A 13 SHEET 10 A11 VAL A 54 VAL A 58 1 O VAL A 54 N ALA A 39 SHEET 11 A11 ALA B 46 LEU B 48 -1 O LEU B 47 N ASP A 57 SHEET 1 B10 VAL B 54 ASP B 57 0 SHEET 2 B10 GLU B 36 ASN B 41 1 N ALA B 39 O LEU B 56 SHEET 3 B10 ILE B 11 ILE B 16 1 N VAL B 13 O GLU B 36 SHEET 4 B10 MET B 95 THR B 99 1 O PHE B 97 N LYS B 12 SHEET 5 B10 LEU B 124 ARG B 131 1 O LEU B 124 N VAL B 96 SHEET 6 B10 THR B 157 PRO B 162 1 O ILE B 159 N GLY B 127 SHEET 7 B10 GLY B 219 ARG B 229 1 O ALA B 221 N LEU B 158 SHEET 8 B10 GLU B 302 ALA B 310 -1 O VAL B 305 N GLY B 226 SHEET 9 B10 GLY B 256 GLY B 263 -1 N GLY B 256 O ALA B 310 SHEET 10 B10 ASN B 288 ILE B 295 1 O ILE B 290 N VAL B 257 SITE 1 AC1 32 GLY A 17 GLY A 18 GLY A 19 ASN A 22 SITE 2 AC1 32 THR A 42 GLY A 67 ALA A 68 GLY A 69 SITE 3 AC1 32 ALA A 70 GLY A 101 GLU A 102 GLY A 104 SITE 4 AC1 32 GLY A 105 THR A 106 GLY A 107 PRO A 132 SITE 5 AC1 32 GLU A 136 ARG A 140 PHE A 180 ALA A 183 SITE 6 AC1 32 ASP A 184 LEU A 187 HOH A 402 HOH A 404 SITE 7 AC1 32 HOH A 413 HOH A 421 HOH A 432 HOH A 436 SITE 8 AC1 32 HOH A 438 HOH A 440 HOH A 462 HOH A 539 SITE 1 AC2 8 ALA A 52 ASP A 53 LYS A 55 MET B 49 SITE 2 AC2 8 SER B 50 ASP B 51 HOH B 428 HOH B 512 CRYST1 88.413 88.413 178.522 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011311 0.006530 0.000000 0.00000 SCALE2 0.000000 0.013060 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005602 0.00000